Pharsight

Patent Number	Company	Patent Title	Patent Expiry	Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7473761	RECORDATI RARE	Somatostatin analogues	Dec, 2026 (4 years from now)
CN1267451C	RECORDATI RARE	Somatostatin Analogues	Jul, 2021 (1 year, 2 months ago)
CN1446229A	RECORDATI RARE	Somatostatin Analogues	Jul, 2021 (1 year, 2 months ago)
IN200300143P4	RECORDATI RARE	Somatostatin Peptidomimetics	Jul, 2021 (1 year, 2 months ago)
IN204073B	RECORDATI RARE	Somatostatin Peptidomimetics	Jul, 2021 (1 year, 2 months ago)
EP1307486B1	RECORDATI RARE	Somatostatin Analogues	Jul, 2026 (3 years from now)
EP1307486A2	RECORDATI RARE	Somatostatin Analogues	Jul, 2026 (3 years from now)
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8822637	RECORDATI RARE	Somatostatin analogues	Aug, 2023 (10 months from now)
US7759308	RECORDATI RARE	Microparticles comprising somatostatin analogues	Oct, 2026 (4 years from now)
US9351923	RECORDATI RARE	Extended-release composition comprising a somatostatin derivative in microparticles	May, 2028 (5 years from now)

Drugs and Companies using PASIREOTIDE PAMOATE ingredient

Treatment: Method of treating acromegaly

Dosage: FOR SUSPENSION;INTRAMUSCULAR

Strength	Dosage	Availability
EQ 10MG BASE/VIAL	FOR SUSPENSION;INTRAMUSCULAR	Prescription
EQ 20MG BASE/VIAL	FOR SUSPENSION;INTRAMUSCULAR	Prescription
EQ 30MG BASE/VIAL	FOR SUSPENSION;INTRAMUSCULAR	Prescription
EQ 40MG BASE/VIAL	FOR SUSPENSION;INTRAMUSCULAR	Prescription
EQ 60MG BASE/VIAL	FOR SUSPENSION;INTRAMUSCULAR	Prescription

availability in other generic markets.

Click on the highlighted region to filter.